vincristine sulfate injection, USP Principal Display Panel

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

PRINCIPAL DISPLAY PANEL - 1 mL Vial Label

1 mL
NDC 61703-309-06
Rx only

VinCRIStine Sulfate Injection, USP
1 mg/mL

Single-dose Vial

For IV Use Only
Cytotoxic Agent

PRINCIPAL DISPLAY PANEL - 1 mL Vial Carton

VIAL

Hospira

1 x 1 mL Vial
NDC 61703-309-06

Sterile
Rx only

VinCRIStine
Sulfate
Injection, USP

1 mg/mL

For Intravenous Use Only

Fatal If Given By Other Routes

Single-dose Vial

Caution: Cytotoxic Agent

PRINCIPAL DISPLAY PANEL - 1 mL Vial Carton

PRINCIPAL DISPLAY PANEL - 2 mL Vial Label

2 mL
NDC 61703-309-16
Rx only

VinCRIStine Sulfate Injection, USP
2 mg/2 mL
(1 mg/mL)

Single-dose Vial

For IV Use Only
Cytotoxic Agent

PRINCIPAL DISPLAY PANEL - 2 mL Vial Carton

VIAL

Hospira

1 x 2 mL Vial
NDC 61703-309-16

Sterile
Rx only

VinCRIStine
Sulfate
Injection, USP

2 mg/2 mL

(1 mg/mL )

For Intravenous Use Only

Fatal If Given By Other Routes

Single-dose Vial

Caution: Cytotoxic Agent

PRINCIPAL DISPLAY PANEL - 2 mL Vial Carton

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

vincristine sulfate injection, USP Quick Finder

Stability Calculator
Pfizer samples (for eligible HCPs)

Requests for samples of prescription medications can be made by contacting Pfizer for Professionals at 1-800-505-4426 or by visiting the PfizerPro website www.pfizerpro.com.
Report an adverse event or concern about the quality of a Pfizer product

To report an adverse event related to Pfizer-BioNTech COVID-19 Vaccine (also known as COMIRNATY®, COVID-19 mRNA, Vaccine BNT162b2 or BNT162) or Pfizer COVID-19 Treatment (also known as PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)), and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly by visiting www.fda.gov/medwatch or by calling (800)-332-1088.
Assistance programs (for eligible patients)

Pfizer RxPathways connects eligible patients to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings. Patients and physicians can contact RxPathways at (866) 706-2400 or visit the website for more information on these programs www.pfizerrxpathways.com.
Resources

Show All Hide All

WARNINGS

Caution–This preparation should be administered by individuals experienced in the administration of Vincristine Sulfate Injection, USP. It is extremely important that the intravenous needle or catheter be properly...